 |
市場調查報告書
商品編碼
2057468
全球高通量篩檢市場：按產品、類型、技術、工作流程、最終用戶、應用和地區分類－預測至2031年High-Throughput Screening Market by Instruments, Consumables, Software, Services, Technology, Workflow, Application, Competition - Global Forecast to 2031 |
||||||
價格
高通量篩檢(HTS) 市場預計將從 2026 年的 276.6 億美元成長到 2031 年的 459 億美元，預測期內複合年成長率為 10.7%。
| 調查範圍 | |
|---|---|
| 調查期 | 2026-2031 |
| 基準年 | 2025 |
| 預測期 | 2026-2031 |
| 目標單元 | 金額（10億美元） |
| 部分 | 按產品/服務、類型、技術、工作流程、最終使用者、應用程式、區域 |
| 目標區域 | 北美、歐洲、亞太地區、拉丁美洲、中東和非洲。 |
促成這一現象的因素包括開放式創新模式的日益普及、政府資助和創業投資投資的增加，以及製藥和生物技術公司研發投入的提高。自動化、高內涵篩檢、細胞檢測、無標定方面的技術進步，進一步提高了篩檢效率，並推動了高通量篩選平台在整個藥物發現流程中的應用。
透過提供產品，預計到 2025 年，該產品細分市場將佔據高通量篩檢(HTS) 市場的最大佔有率。
從產品供應角度來看，高通量篩檢(HTS) 市場分為產品與服務兩大類。預計到 2025 年，產品類市場將佔據高通量篩檢(HTS) 市場的最大佔有率。這主要得益於市場對檢測試劑盒、試劑、耗材、微孔盤、化合物庫、儀器、軟體和自動化平台等產品的持續需求。由於 HTS 工作流程需要在從檢測方法開發和篩檢到數據分析和結果確認的各個階段持續使用耗材和整合儀器，因此產品類市場將繼續保持其主導地位。此外，自動化液體處理工作站、微孔盤讀數儀、高內涵成像系統和即用型檢測試劑盒的快速普及也進一步提升了產品類市場在 HTS 市場的收入貢獻。
按應用領域分類，預計到 2025 年，藥物發現和開發領域將在高通量篩檢(HTS) 市場中佔據最大佔有率。
按應用領域分類，高通量篩檢(HTS) 市場可細分為藥物發現與開發、基礎研究與功能基因組學、毒理學與安全性篩檢、精準醫療與生物標記發現、幹細胞與再生醫學研究以及其他應用。預計到 2025 年，藥物發現與開發領域將佔據高通量篩檢(HTS) 市場的最大佔有率。這是因為 HTS 被廣泛用於篩檢大型化合物庫、檢驗先導化合物、驗證標靶以及支援先導化合物的最佳化。製藥和生物技術公司持續依賴 HTS 平台來提高早期藥物發現的效率，並縮短候選化合物進入臨床前開發階段的時間。此外，表現型篩檢、基於細胞的檢測、3D 模型和高內涵成像等技術的日益普及也推動了該領域的發展，使其能夠識別更多具有生物學相關性的候選藥物。
從 2026 年到 2031 年，亞太地區預計將成為高通量篩檢(HTS) 市場中複合年成長率最高的地區。
高通量篩檢(HTS) 市場按地區分類為北美、歐洲、亞太、拉丁美洲以及中東和非洲。預計亞太地區在預測期內將以顯著的複合年成長率成長。這一成長主要得益於製藥和生物技術領域研發活動的不斷拓展、合約研究組織 (CRO) 的日益普及以及藥物發現基礎設施投資的增加。中國、印度、日本和韓國等國家正透過增加研究經費、提高外包需求以及採用自動化實驗室技術來增強其篩檢能力。此外，該地區還受益於成本效益高的研究營運、生物技術新創公司的蓬勃發展以及全球製藥公司與本地藥物發現服務供應商之間日益密切的合作。
Thermo Fisher Scientific Inc.（美國）、Agilent Technologies, Inc.（美國）、Merck KGaA（德國）、Danaher Corporation（美國）、Revvity, Inc.（美國）、Tecan Group Ltd.（瑞士）、Bio-Rad Laboratories, Inc.（美國）、Corning Incorporated（美國）、Mettler-Tole Corporation（美國）、Corning Incorporated（美國）、Mettler-Tole Corporation（瑞士））、Corning Incorporated（美國）、Mettler？ AG（德國）、Eppendorf SE（德國）、Porvair Plc（英國）、Greiner AG（奧地利）、Charles River Laboratories（美國）、Eurofins Scientific（盧森堡）和Hamilton Company（美國）是提供高通量篩選解決方案的一些領先公司。
調查範圍
本研究報告從產品和服務、產品類型（儀器、試劑/試劑盒/耗材、軟體/資訊學和服務）、技術（生化篩檢技術、基於細胞的篩檢技術、高內涵篩檢(HCS) 技術、無標定篩檢技術、微流體/微型化篩檢技術、3D細胞培養/先進細胞篩檢技術、超高通量/自動化技術以及人工智慧/電腦輔助篩檢技術）、工作流程（檢測方法開發/最佳化、化合物樣品製備、高通量篩檢、數據分析/先導化合物識別、先導化合物確認、先導化合物檢驗/表徵）以及最終用戶（數據按以下類別分類：製藥和生物技術公司、CRO/CDMO、學術和研究機構以及其他最終用戶；服務類型（檢測方法開發和最佳化服務、化合物庫管理服務、篩檢服務、複篩檢和先導化合物確認服務、先導化合物檢驗和表徵服務、數據分析和資訊學）對高通量篩選(HTS) 市場進行篩檢。
本報告深入分析了影響高通量篩檢(HTS) 市場成長的關鍵因素，包括促進因素、挑戰、機會和限制因素。報告全面分析了主要行業參與企業，深入剖析了他們的業務概況、產品和服務組合以及關鍵策略，包括夥伴關係、擴張、協議、收購以及 HTS 市場的最新篩檢。該報告還對 HTS 市場生態系統中的主要參與者和新興新創公司進行了競爭分析。此外，報告詳細闡述了影響市場篩檢的關鍵因素，例如促進因素、限制因素、挑戰和機遇，並對主要產業參與者的解決方案生態系統、產品、近期產品發布、併購以及新興市場趨勢進行了詳細評述。
購買本報告的主要好處
本報告全面概述了高通量篩檢(HTS) 市場，旨在評估各細分市場的規模和未來成長機會。該報告還對主要市場參與企業公司簡介、近期發展和關鍵市場策略。
本報告深入分析了以下幾點：
對關鍵促進因素（廣泛採用開放式創新模式、研發資金和公私投資增加、實驗室自動化和機器人篩檢平台廣泛採用，以及將篩檢操作外包給 CRO 和 HTS服務供應商）的限制阻礙因素（HTS 設備高成本、檢測開發和驗證複雜）、機會（新興市場對 HTS 技術的採用率提高，以及 HTS 在藥物應用和個人化分析檢測、類器官檢測和基於影像的檢測標準化方面的挑戰）的分析。
- 產品與服務開發與創新：對新推出的產品與服務進行詳細分析，並對高通量篩檢(HTS) 市場進行技術評估。
- 市場發展：提供盈利市場的全面資訊。本報告分析了不同地區的高通量篩檢(HTS) 市場。
- 市場多元化：有關高通量篩檢(HTS) 市場中尚未開發的新地區、近期趨勢和投資機會的全面資訊。
競爭評估：本報告分析了高通量篩選 (HTS) 市場主要參與者的商業策略和產品線，包括 Thermo Fisher Scientific Inc.（美國）、Agilent Technologies, Inc.（美國）、Merck KGaA（德國）、Danaher Corporation（美國）、Revvity, Inc.（美國）、Tecan Group Ltd.（瑞士）、Bio-Rad Laborator, Inc. Incorporated（美國）、Mettler-Toledo International Inc.（美國）、Lonza Group（瑞士）、Waters Corporation（美國）、Sartorius AG（德國）、Eppendorf SE（德國）、Porvair Plc（英國）、Greiner AG（奧地利）、Charles River 篩檢（美國）、Eurofins）。
此外，本報告幫助相關人員了解高通量篩檢(HTS) 市場的趨勢，提供關鍵促進因素、限制、挑戰和機會的資訊。該報告對主要行業參與企業進行了詳細分析，深入剖析了 HTS 行業的市場策略、產品和服務發布、收購、夥伴關係、聯盟、近期活動、投資、資金籌措、品牌和產品對比、供應商評估以及財務指標。
目錄
第1章：引言
第2章執行摘要
第3章重要考察
第4章 市場概覽
- 市場動態
- 促進因素
- 抑制因子
- 機會
- 任務
- 未滿足的需求和未開發的領域
- 相互關聯的市場與跨產業機遇
- 一級/二級/三級公司的策略性舉措
第5章 產業趨勢
- 波特五力分析
- 宏觀經濟展望
- 價值鏈分析
- 生態系分析
- 價格分析
- 貿易分析
- 2026-2027 年主要會議和活動
- 影響我們客戶公司業務的趨勢/變化
- 投資和資金籌措場景
- 2025年美國關稅對高通量篩檢（HTS）市場的影響
第6章：技術進步、人工智慧的影響、專利與創新
- 技術分析
- 技術/產品藍圖
- 專利分析
- 未來應用
- 人工智慧/生成式人工智慧對高通量篩檢（HTS）市場的影響
第7章永續性和監管情勢
- 當地法規和合規性
- 監管機構、政府機構和其他組織
- 業界標準
- 對永續性的承諾
- 對永續性和監管政策舉措的影響
- 認證、標籤檢視和環境標準
第8章：顧客趨勢與購買行為
- 決策流程
- 買方相關人員和採購評估標準
- 實施障礙和內部挑戰
- 各個終端用戶產業尚未滿足的需求
- 市場盈利
第9章：高通量篩檢市場（依產品/服務分類）
- 產品
- 服務
第10章：高通量篩檢產品市場（按類型分類）
- 試劑、試劑盒、耗材
- 裝置
- 軟體與資訊學
第11章：高通量篩檢產品市場（依技術分類）
- 基於細胞的篩檢技術
- 超高吞吐量和自動化技術
- 高內涵篩檢（HCS）技術
- 生化篩檢技術
- 3D細胞培養與先進細胞模型技術
- 無標定篩檢技術
- 其他
第12章：高通量篩檢產品市場（依工作流程分類）
- 篩檢
- 檢測方法開發與最佳化
- 命中確認/二次篩檢
- 數據分析和命中識別
- 化合物庫的構建
- 命中檢驗和特徵評估
第13章：高通量篩檢產品市場（依最終用戶分類）
- 製藥和生物技術公司
- CRO &CDMO
- 學術和研究機構
- 其他
第14章：高通量篩檢服務市場（依類型分類）
- 初級篩檢服務
- 檢測方法開發與最佳化服務
- 二次篩檢和命中確認服務
- 命中檢驗和特徵分析服務
- 綜合圖書館管理服務
- 數據分析和資訊服務
- 其他
第15章：高通量篩檢服務市場（依最終用戶分類）
- 製藥和生物技術公司
- 學術和研究機構
- 其他
第16章：高通量篩檢市場（依應用領域分類）
- 藥物發現與開發
- 基礎研究與功能基因體學
- 毒理學和安全性篩檢
- 精準醫療和生物標記發現
- 幹細胞和再生醫學調查
- 其他
第17章：高通量篩檢市場（依地區分類）
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他
- 亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 其他
- 拉丁美洲
- 巴西
- 墨西哥
- 其他
- 中東
- 海灣合作理事會國家
- 其他
- 非洲
- 感染疾病研究和合作發現網路正在推動市場成長。
第18章 競爭格局
- 概述
- 關鍵企業策略/優勢
- 2021-2025年收入分析
- 2025年市佔率分析
- 企業估值象限：主要參與企業，2025 年
- 公司估值矩陣：新創企業/中小企業，2025 年
- 企業估值和財務指標
- 品牌/產品/服務比較
- 競爭格局
第19章：公司簡介
- 大公司
- THERMO FISHER SCIENTIFIC INC.
- DANAHER CORPORATION
- MERCK KGAA
- AGILENT TECHNOLOGIES, INC.
- REVVITY, INC.
- TECAN GROUP LTD.
- BIO-RAD LABORATORIES, INC.
- CORNING INCORPORATED
- METTLER-TOLEDO INTERNATIONAL INC.
- LONZA GROUP
- WATERS CORPORATION
- SARTORIUS AG
- EPPENDORF SE
- PORVAIR PLC
- GREINER AG
- CHARLES RIVER LABORATORIES
- EUROFINS SCIENTIFIC
- HAMILTON COMPANY
- AURORA BIOMED INC.
- GILSON INCORPORATED
- BRAND GMBH+CO KG
- 其他公司
- BMG LABTECH GMBH
- DIANA BIOTECHNOLOGIES, AS
- CREATIVE BIOLABS
- HIGHRES BIOSOLUTIONS
- BIOMAT SRL
- AXXAM SPA
- SYGNATURE DISCOVERY LIMITED
- CROWN BIOSCIENCE
第20章：調查方法
第21章附錄
Product Code: BT 2220
The high-throughput screening (HTS) market is expected to reach USD 45.90 billion in 2031 from USD 27.66 billion in 2026, growing at a CAGR of 10.7% during the forecast period.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2026-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | Offering, Products by Type, Application, and Region |
| Regions covered | North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. |
Factors such as the rising adoption of open innovation models, increasing government funding and venture capital investments, and higher R&D spending by pharmaceutical and biotechnology companies. Technological advancements in automation, high-content screening, cell-based assays, label-free detection, and AI-enabled data analysis are further improving screening efficiency and supporting wider adoption of HTS platforms across drug discovery workflows.
By offering, the products segment accounted for the largest share of the high-throughput screening (HTS) market in 2025.
Based on offering, the high-throughput screening (HTS) market is segmented into products and services. In 2025, the products segment held the largest share of the high-throughput screening (HTS) market. This is driven by recurring demand for assay kits, reagents, consumables, microplates, compound libraries, instruments, software, and automation platforms. The segment remains dominant because HTS workflows require continuous use of consumables and integrated instruments throughout assay development, screening, data analysis, and hit confirmation. Strong adoption of automated liquid handlers, microplate readers, high-content imaging systems, and assay-ready kits further supports the revenue contribution of products in the HTS market.
By application, the drug discovery & development segment accounted for the largest share of the high-throughput screening (HTS) market in 2025.
By application, the high-throughput screening (HTS) market is divided into drug discovery & development, basic research & functional genomics, toxicology & safety screening, precision medicine & biomarker discovery, stem cell & regenerative medicine research, and other applications. In 2025, the drug discovery & development segment held the largest share of the high-throughput screening (HTS) market, as HTS is widely used to screen large compound libraries, identify hits, validate targets, and support lead optimization. Pharmaceutical and biotechnology companies continue to rely on HTS platforms to improve early-stage discovery productivity and reduce the time required to move candidates into preclinical development. The segment also benefits from the growing use of phenotypic screening, cell-based assays, 3D models, and high-content imaging to identify more biologically relevant drug candidates.
The Asia Pacific region is expected to grow at the highest CAGR in the high-throughput screening (HTS) market from 2026 to 2031.
The high-throughput screening (HTS) market is divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific region is expected to grow at a significant CAGR during the forecast period. This increase is driven by expanding pharmaceutical and biotechnology R&D activity, growing CRO presence, and increasing investments in drug discovery infrastructure. Countries such as China, India, Japan, and South Korea are strengthening their screening capabilities through rising research funding, outsourcing demand, and the adoption of automated laboratory technologies. The region is also benefiting from cost-efficient research operations, expanding biotech start-up activity, and increasing partnerships between global pharma companies and local discovery service providers.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side (80%) and Demand Side (20%)
- By Designation: Managers (45%), CXOs & Directors (30%), and Executives (25%)
- By Region: North America (40%), Europe (25%), Asia Pacific (25%), Latin America (5%), the Middle East & Africa (5%)
Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Revvity, Inc. (US), Tecan Group Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Corning Incorporated (US), Mettler-Toledo International Inc. (US), Lonza Group (Switzerland), Waters Corporation (US), Sartorius AG (Germany), Eppendorf SE (Germany), Porvair Plc (UK), Greiner AG (Austria), Charles River Laboratories (US), Eurofins Scientific (Luxembourg), and Hamilton Company (US) are some of the key companies offering HTS solutions.
Research Coverage
This research report categorizes the high-throughput screening (HTS) market by offering (products and services), products by type (instruments; reagents, kits, and consumables; software & informatics; and services), products by technology (biochemical screening technologies, cell-based screening technologies, high-content screening (HCS) technologies, label-free screening technologies, microfluidic & miniaturized screening technologies, 3D cell culture & advanced cellular model technologies, ultra-high-throughput & automation technologies, and AI-enabled & computational screening technologies), products by workflow (assay development & optimization, compound library preparation, high-throughput screening, data analysis & hit identification, hit confirmation, hit validation & characterization), products by end user (pharmaceutical & biotechnology companies, CROs & CDMOs, academic & research institutes, and other end users), services by type (assay development & optimization services, compound library management services, primary screening services, secondary screening & hit confirmation services, hit validation & characterization services, data analysis & informatics services, and other services), services by end user (pharmaceutical & biotechnology companies, academic & research institutes, and other end users), application (drug discovery & development, basic research & functional genomics, toxicology & safety screening, precision medicine & biomarker discovery, stem cell & regenerative medicine research, and other applications), and region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).
The scope of the report provides detailed information on major factors such as drivers, challenges, opportunities, and restraints that influence the growth of the high-throughput screening (HTS) market. A comprehensive analysis of key industry players has been conducted to provide insights into their business overviews, product/service portfolios, and key strategies, including collaborations, partnerships, expansions, agreements, acquisitions, and recent developments in the high-throughput screening (HTS) market. This report includes a competitive analysis of top players and upcoming startups in the high-throughput screening (HTS) market ecosystem. The report also details primary factors like drivers, restraints, challenges, and opportunities shaping the market growth, along with an in-depth review of key industry players' solutions, products, recent product launches, mergers, acquisitions, and emerging market trends ecosystem.
Key Benefits of Buying the Report
This report offers a comprehensive overview of the high-throughput screening (HTS) market. It aims to assess the market size and future growth opportunities across various segments. The report also features an in-depth competitive analysis of the major market players, including their company profiles, recent developments, and key market strategies.
The report provides insights into the following pointers:
Analysis of key drivers (growing adoption of open innovative models, growing R&D funding and increasing public & private investments, growing adoption of lab automation and robotic screening platforms, and increasing outsourcing of screening activities to CROs and HTS service providers), restraints (high costs associated with HTS instruments and complexity in assay development and validation), opportunities (increasing adoption of HTS technologies in emerging markets and growing application of HTS in drug repurposing and personalized medicine), and challenges (complexity in data management & analysis, standardization challenges in 3D, organoid, and image-based assays)
- Product/Service Development/Innovation: Detailed insights on newly launched products/services, and technological assessment of the high-throughput screening (HTS) market.
- Market Development: Comprehensive information about lucrative markets; the report analyzes the high-throughput screening (HTS) market across varied regions.
- Market Diversification: Exhaustive information about new, untapped geographies, recent developments, and investments in the high-throughput screening (HTS) market
Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Revvity, Inc. (US), Tecan Group Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Corning Incorporated (US), Mettler-Toledo International Inc. (US), Lonza Group (Switzerland), Waters Corporation (US), Sartorius AG (Germany), Eppendorf SE (Germany), Porvair Plc (UK), Greiner AG (Austria), Charles River Laboratories (US), Eurofins Scientific (Luxembourg), and Hamilton Company (US), among others, in the high-throughput screening (HTS) market.
The report also helps stakeholders understand trends in the high-throughput screening (HTS) market and provides information on key drivers, restraints, challenges, and opportunities. A detailed analysis of the key industry players has been conducted to offer insights into their strategies, product/service launches, acquisitions, partnerships, collaborations, recent activities, investments, funding, brand and product comparisons, vendor evaluations, and financial metrics of the HTS sector market.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION & REGIONS COVERED
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
- 1.4 STAKEHOLDERS
- 1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
- 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS
- 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
- 2.3 DISRUPTIVE TRENDS IN HIGH-THROUGHPUT SCREENING MARKET
- 2.4 HIGH-GROWTH SEGMENTS
- 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 HIGH-THROUGHPUT SCREENING MARKET OVERVIEW
- 3.2 NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT TYPE AND COUNTRY
- 3.3 HIGH-THROUGHPUT SCREENING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- 3.4 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET SHARE, BY END USER, 2026 VS 2031 (%)
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Growing adoption of open innovative models
- 4.2.1.2 Technological advancements
- 4.2.1.3 Growing R&D funding and increasing public & private investments
- 4.2.1.4 Growing adoption of lab automation & robotic screening platforms
- 4.2.1.5 Increasing outsourcing of screening activities to CROs & CDMOs
- 4.2.2 RESTRAINTS
- 4.2.2.1 High costs associated with HTS instruments
- 4.2.2.2 Complexity in assay development and validation
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Increasing adoption of HTS technologies in emerging markets
- 4.2.3.2 Growing application of HTS in drug repurposing and personalized medicine
- 4.2.3.3 Expansion of CRISPR, RNAi, and functional genomics screening
- 4.2.4 CHALLENGES
- 4.2.4.1 Complexity in data management and analysis
- 4.2.1 DRIVERS
- 4.3 UNMET NEEDS & WHITE SPACES
- 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 INTENSITY OF COMPETITIVE RIVALRY
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 BARGAINING POWER OF BUYERS
- 5.1.4 THREAT OF SUBSTITUTES
- 5.1.5 THREAT OF NEW ENTRANTS
- 5.2 MACROECONOMIC OUTLOOK
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS & FORECAST
- 5.2.3 TRENDS IN GLOBAL HIGH-THROUGHPUT SCREENING INDUSTRY
- 5.3 VALUE CHAIN ANALYSIS
- 5.4 ECOSYSTEM ANALYSIS
- 5.5 PRICING ANALYSIS
- 5.5.1 AVERAGE SELLING PRICE TREND OF HTS PRODUCTS, BY KEY PLAYER, 2023-2025
- 5.5.2 AVERAGE SELLING PRICE TREND OF HTS PRODUCTS, BY REGION, 2023-2025
- 5.6 TRADE ANALYSIS
- 5.6.1 IMPORT SCENARIO (HS CODE 902730 & 902781)
- 5.6.2 EXPORT SCENARIO (HS CODE 902730& 902781)
- 5.7 KEY CONFERENCES & EVENTS, 2026-2027
- 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.9 INVESTMENT & FUNDING SCENARIO
- 5.10 IMPACT OF 2025 US TARIFFS ON HIGH-THROUGHPUT SCREENING (HTS) MARKET
- 5.10.1 INTRODUCTION
- 5.10.2 KEY TARIFF RATES
- 5.10.3 PRICE IMPACT ANALYSIS
- 5.10.4 IMPACT ON COUNTRIES/REGIONS
- 5.10.4.1 US
- 5.10.4.2 Europe
- 5.10.4.3 Asia Pacific
- 5.10.5 IMPACT ON END-USE INDUSTRIES
- 5.10.5.1 Pharmaceutical & biotechnology companies
- 5.10.5.2 CROs & CDMOs
- 5.10.5.3 Academic & research institutes
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS
- 6.1 TECHNOLOGICAL ANALYSIS
- 6.1.1 KEY EMERGING TECHNOLOGIES
- 6.1.1.1 High-content screening
- 6.1.1.2 Label-free detection
- 6.1.1.3 Microfluidics
- 6.1.2 COMPLEMENTARY TECHNOLOGIES
- 6.1.2.1 Laboratory automation & robotic integration
- 6.1.2.2 Mass spectrometry
- 6.1.2.3 Flow cytometry
- 6.1.3 ADJACENT TECHNOLOGIES
- 6.1.3.1 Fragment-based drug discovery
- 6.1.3.2 Bioinformatics & cheminformatics
- 6.1.1 KEY EMERGING TECHNOLOGIES
- 6.2 TECHNOLOGY/PRODUCT ROADMAP
- 6.3 PATENT ANALYSIS
- 6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR HIGH-THROUGHPUT SCREENING PATENTS, 2015-2025
- 6.4 FUTURE APPLICATIONS
- 6.5 IMPACT OF AI/GEN AI ON HIGH-THROUGHPUT SCREENING (HTS) MARKET
- 6.5.1 BEST PRACTICES IN HTS WORKFLOW
- 6.5.2 CASE STUDIES OF AI IMPLEMENTATION IN HIGH-THROUGHPUT SCREENING (HTS) MARKET
- 6.5.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
- 6.5.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN HIGH-THROUGHPUT SCREENING (HTS) MARKET
7 SUSTAINABILITY & REGULATORY LANDSCAPE
- 7.1 REGIONAL REGULATIONS & COMPLIANCE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.2 INDUSTRY STANDARDS
- 7.2 SUSTAINABILITY INITIATIVES
- 7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
- 7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 8.1 DECISION-MAKING PROCESS
- 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
- 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.2.2 KEY BUYING CRITERIA, BY END USER
- 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
- 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
- 8.5 MARKET PROFITABILITY
9 HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING
- 9.1 INTRODUCTION
- 9.2 PRODUCTS
- 9.2.1 RECURRING CONSUMABLES DEMAND, AUTOMATION UPGRADES, AND ADVANCED SCREENING PLATFORMS TO DRIVE MARKET GROWTH
- 9.3 SERVICES
- 9.3.1 RISING OUTSOURCING OF ASSAY DEVELOPMENT, PRIMARY SCREENING, AND DATA ANALYSIS TO DRIVE GROWTH OF HTS SERVICES MARKET
10 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE
- 10.1 INTRODUCTION
- 10.2 REAGENTS, KITS, AND CONSUMABLES
- 10.2.1 SCREENING ASSAY KITS
- 10.2.1.1 Cell-based assays
- 10.2.1.1.1 Cell viability assays
- 10.2.1.1.1.1 Increasing use of viability readouts across oncology and toxicity screening to sustain assay kit demand
- 10.2.1.1.2 Cytotoxicity assays
- 10.2.1.1.2.1 Rising focus on early toxicity detection to improve lead selection and reduce drug development risk
- 10.2.1.1.3 Reporter gene assays
- 10.2.1.1.3.1 Growing use of pathway-specific functional readouts to strengthen reporter gene assay adoption
- 10.2.1.1.4 Other cell-based assays
- 10.2.1.1.1 Cell viability assays
- 10.2.1.2 Biochemical assays
- 10.2.1.2.1 Enzyme assays
- 10.2.1.2.1.1 Broad use of enzyme activity profiling in target-based drug discovery to sustain demand for enzyme assay kits
- 10.2.1.2.2 Kinase assays
- 10.2.1.2.2.1 Continued investment in targeted kinase inhibitor discovery to drive kinase assay kit demand
- 10.2.1.2.3 Binding assays
- 10.2.1.2.3.1 Rising use of target engagement and affinity profiling to improve hit validation quality
- 10.2.1.2.4 Other biochemical assays
- 10.2.1.2.1 Enzyme assays
- 10.2.1.3 Other assays & kits
- 10.2.1.1 Cell-based assays
- 10.2.2 BIOLOGICAL & CELL CULTURE REAGENTS
- 10.2.2.1 Rising use of disease-relevant cellular models to strengthen demand for biological and cell culture reagents
- 10.2.3 COMPOUND LIBRARIES
- 10.2.3.1 Expansion of focused and repurpose libraries to support compound library demand
- 10.2.4 DETECTION REAGENTS
- 10.2.4.1 Increasing adoption of fluorescence, luminescence, and biomarker-based readouts to drive detection reagent use
- 10.2.5 3D CELL CULTURE PRODUCTS
- 10.2.5.1 Scaffold-based 3D cell culture products
- 10.2.5.1.1 Rising demand for matrix-supported disease models to drive scaffold-based 3D culture product growth
- 10.2.5.2 Scaffold-free 3D cell culture products
- 10.2.5.2.1 Increasing use of spheroid-based screening to support scaffold-free 3D culture product adoption
- 10.2.5.3 Other 3D cell culture products
- 10.2.5.1 Scaffold-based 3D cell culture products
- 10.2.6 OTHER HTS CONSUMABLES
- 10.2.1 SCREENING ASSAY KITS
- 10.3 INSTRUMENTS
- 10.3.1 DETECTION & IMAGING SYSTEMS
- 10.3.1.1 Microplate readers
- 10.3.1.1.1 Growing use of multiplexed biochemical and cell-based assays to support microplate reader demand
- 10.3.1.2 High-content screening (HCS) & imaging systems
- 10.3.1.2.1 Increasing adoption of phenotypic screening and AI-based cellular analysis to drive growth of HCS systems
- 10.3.1.3 Cell analysis systems
- 10.3.1.3.1 Growing use of cell-based screening and functional biology assays to strengthen demand for cell analysis systems
- 10.3.1.4 Label-free detection systems
- 10.3.1.4.1 Rising need for real-time biomolecular interaction analysis to support adoption of label-free detection systems
- 10.3.1.5 Microfluidic & miniaturized screening systems
- 10.3.1.5.1 Assay miniaturization to drive adoption of microfluidic screening systems
- 10.3.1.1 Microplate readers
- 10.3.2 LIQUID HANDLING & AUTOMATION SYSTEMS
- 10.3.2.1 Increasing assay miniaturization and workflow standardization to drive growth of liquid handling & automation systems
- 10.3.3 ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS
- 10.3.3.1 Rising deployment of end-to-end laboratory automation systems to accelerate robotic HTS platform adoption
- 10.3.4 OTHER HTS INSTRUMENTS
- 10.3.1 DETECTION & IMAGING SYSTEMS
- 10.4 SOFTWARE & INFORMATICS
- 10.4.1 BIOINFORMATICS TOOLS TO HELP TURN RAW DATA INTO MEANINGFUL INSIGHTS
11 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY
- 11.1 INTRODUCTION
- 11.2 CELL-BASED SCREENING TECHNOLOGIES
- 11.2.1 INCREASING ADOPTION OF PHYSIOLOGICALLY RELEVANT PHENOTYPIC SCREENING WORKFLOWS TO STRENGTHEN CELL-BASED TECHNOLOGY DEMAND
- 11.3 ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES
- 11.3.1 GROWING DEMAND FOR SCALABLE ROBOTIC INFRASTRUCTURE & INTEGRATED AUTOMATION PLATFORMS TO SUPPORT MARKET GROWTH
- 11.4 HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES
- 11.4.1 RISING ADOPTION OF AI-POWERED PHENOTYPIC IMAGING AND MULTIPARAMETRIC CELLULAR PROFILING TO ACCELERATE HCS TECHNOLOGY GROWTH
- 11.5 BIOCHEMICAL SCREENING TECHNOLOGIES
- 11.5.1 CONTINUED EXPANSION OF TARGET-BASED DRUG DISCOVERY PROGRAMS TO SUSTAIN BIOCHEMICAL SCREENING PRODUCT DEMAND
- 11.6 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES
- 11.6.1 RISING ADOPTION OF ORGANOIDS, SPHEROIDS, AND TISSUE-LIKE SCREENING SYSTEMS TO ACCELERATE 3D CELLULAR TECHNOLOGY GROWTH
- 11.7 LABEL-FREE SCREENING TECHNOLOGIES
- 11.7.1 INCREASING USE OF REAL-TIME BINDING KINETICS AND BIOPHYSICAL PROFILING TO SUPPORT LABEL-FREE SCREENING ADOPTION
- 11.8 OTHER HTS TECHNOLOGIES
12 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW
- 12.1 INTRODUCTION
- 12.2 PRIMARY SCREENING
- 12.2.1 LARGE-SCALE COMPOUND SCREENING REQUIREMENTS TO SUSTAIN PRODUCT DEMAND ACROSS PRIMARY HTS WORKFLOWS
- 12.3 ASSAY DEVELOPMENT & OPTIMIZATION
- 12.3.1 RISING NEED FOR ROBUST, MINIATURIZED, AND AUTOMATION-COMPATIBLE ASSAYS TO SUPPORT ASSAY DEVELOPMENT PRODUCT DEMAND
- 12.4 HIT CONFIRMATION/SECONDARY SCREENING
- 12.4.1 RISING FOCUS ON HIT QUALITY ASSESSMENT AND FALSE-POSITIVE REDUCTION TO SUPPORT SECONDARY SCREENING PRODUCT DEMAND
- 12.5 DATA ANALYSIS & HIT IDENTIFICATION
- 12.5.1 INCREASING INTEGRATION OF AI-DRIVEN ANALYTICS AND IMAGE-BASED SCREENING DATA TO ACCELERATE HIT IDENTIFICATION WORKFLOWS
- 12.6 COMPOUND LIBRARY PREPARATION
- 12.6.1 EXPANSION OF LARGE-SCALE AND FOCUSED SCREENING LIBRARIES TO STRENGTHEN DEMAND FOR COMPOUND PREPARATION PRODUCTS
- 12.7 HIT VALIDATION & CHARACTERIZATION
- 12.7.1 GROWING FOCUS ON PHENOTYPIC CHARACTERIZATION WORKFLOWS TO DRIVE HIT VALIDATION PRODUCT DEMAND
13 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER
- 13.1 INTRODUCTION
- 13.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 13.2.1 SUSTAINED BIOPHARMA R&D INVESTMENT AND AUTOMATION-LED DRUG DISCOVERY TO DRIVE HTS PRODUCT ADOPTION
- 13.3 CROS & CDMOS
- 13.3.1 RISING DISCOVERY OUTSOURCING AND CRO PLATFORM EXPANSION TO ACCELERATE HTS PRODUCT DEMAND
- 13.4 ACADEMIC & RESEARCH INSTITUTES
- 13.4.1 PUBLIC RESEARCH FUNDING AND TRANSLATIONAL BIOLOGY PROGRAMS TO SUPPORT HTS PRODUCT UPTAKE IN RESEARCH INSTITUTES
- 13.5 OTHER END USERS
14 HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE
- 14.1 INTRODUCTION
- 14.2 PRIMARY SCREENING SERVICES
- 14.2.1 RISING HIGH-VOLUME SCREENING REQUIREMENTS TO DRIVE GROWTH OF PRIMARY HTS SCREENING SERVICES
- 14.3 ASSAY DEVELOPMENT & OPTIMIZATION SERVICES
- 14.3.1 INCREASING DEMAND FOR CUSTOMIZED AND MINIATURIZED ASSAYS TO SUPPORT ASSAY DEVELOPMENT SERVICE ADOPTION
- 14.4 SECONDARY SCREENING & HIT CONFIRMATION SERVICES
- 14.4.1 INCREASING EMPHASIS ON HIT VALIDATION AND SELECTIVITY ASSESSMENT TO SUPPORT SECONDARY SCREENING SERVICES
- 14.5 HIT VALIDATION & CHARACTERIZATION SERVICES
- 14.5.1 GROWING NEED FOR MECHANISM-OF-ACTION PROFILING TO STRENGTHEN HIT CHARACTERIZATION SERVICE ADOPTION
- 14.6 COMPOUND LIBRARY MANAGEMENT SERVICES
- 14.6.1 EXPANSION OF LARGE-SCALE SCREENING LIBRARIES TO STRENGTHEN DEMAND FOR COMPOUND MANAGEMENT SERVICES
- 14.7 DATA ANALYSIS & INFORMATICS SERVICES
- 14.7.1 GROWING ADOPTION OF AI-ENABLED SCREENING ANALYTICS AND IMAGE-BASED DATA INTERPRETATION TO DRIVE HTS INFORMATICS SERVICES GROWTH
- 14.8 OTHER HTS SERVICES
15 HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER
- 15.1 INTRODUCTION
- 15.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 15.2.1 INCREASING COMPLEXITY OF DRUG DISCOVERY WORKFLOWS TO STRENGTHEN OUTSOURCING OF HTS SERVICES BY PHARMA AND BIOTECH COMPANIES
- 15.3 ACADEMIC & RESEARCH INSTITUTES
- 15.3.1 LIMITED IN-HOUSE AUTOMATION CAPACITY TO DRIVE ACADEMIC OUTSOURCING OF HTS SERVICES
- 15.4 OTHER END USERS
16 HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION
- 16.1 INTRODUCTION
- 16.2 DRUG DISCOVERY & DEVELOPMENT
- 16.2.1 INCREASING PHARMACEUTICAL R&D INVESTMENTS AND EXPANSION OF TARGET-BASED AND PHENOTYPIC DRUG DISCOVERY PROGRAMS TO DRIVE MARKET GROWTH
- 16.3 BASIC RESEARCH & FUNCTIONAL GENOMICS
- 16.3.1 GROWING ADOPTION OF CRISPR SCREENING, FUNCTIONAL GENOMICS, AND DISEASE PATHWAY CHARACTERIZATION TO DRIVE HTS DEMAND
- 16.4 TOXICOLOGY & SAFETY SCREENING
- 16.4.1 INCREASING EMPHASIS ON PREDICTIVE TOXICOLOGY AND REGULATORY PRESSURE TO REDUCE ANIMAL TESTING TO ACCELERATE HTS ADOPTION
- 16.5 PRECISION MEDICINE & BIOMARKER DISCOVERY
- 16.5.1 EXPANSION OF BIOMARKER-GUIDED THERAPEUTICS AND PERSONALIZED MEDICINE PIPELINES TO DRIVE RAPID GROWTH IN PRECISION MEDICINE SCREENING APPLICATIONS
- 16.6 STEM CELL & REGENERATIVE MEDICINE RESEARCH
- 16.6.1 GROWING DEVELOPMENT OF CELL THERAPIES AND REGENERATIVE MEDICINE PRODUCTS IS SUPPORTING HTS ADOPTION IN STEM CELL RESEARCH
- 16.7 OTHER APPLICATIONS
17 HIGH-THROUGHPUT SCREENING MARKET, BY REGION
- 17.1 INTRODUCTION
- 17.2 NORTH AMERICA
- 17.2.1 US
- 17.2.1.1 Advanced automation, strong drug discovery infrastructure, and AI-enabled screening workflows to support market growth
- 17.2.2 CANADA
- 17.2.2.1 Academic screening infrastructure to support market growth
- 17.2.1 US
- 17.3 EUROPE
- 17.3.1 GERMANY
- 17.3.1.1 Increasing product launches and investments to boost market growth
- 17.3.2 UK
- 17.3.2.1 Industrial-scale screening access and academic HTS infrastructure to support market
- 17.3.3 FRANCE
- 17.3.3.1 Large pharmaceutical R&D expenditure to drive market growth
- 17.3.4 ITALY
- 17.3.4.1 Functional genomics and automated screening platforms to fuel growth
- 17.3.5 SPAIN
- 17.3.5.1 Academic screening platforms, chemical biology networks, and assay automation to boost market
- 17.3.6 REST OF EUROPE
- 17.3.1 GERMANY
- 17.4 ASIA PACIFIC
- 17.4.1 CHINA
- 17.4.1.1 Automation-led drug discovery and CRO-led screening capacity expansion to support growth of market
- 17.4.2 JAPAN
- 17.4.2.1 Advanced screening platforms and integrated drug discovery partnerships to support market growth
- 17.4.3 INDIA
- 17.4.3.1 Automation-led CRO expansion and biopharma R&D infrastructure growth to fuel market
- 17.4.4 AUSTRALIA
- 17.4.4.1 Robotic screening infrastructure and translational drug discovery programs to drive market growth
- 17.4.5 SOUTH KOREA
- 17.4.5.1 AI-enhanced screening platforms and translational R&D collaborations to favor market growth
- 17.4.6 REST OF ASIA PACIFIC (ROAPAC)
- 17.4.1 CHINA
- 17.5 LATIN AMERICA
- 17.5.1 BRAZIL
- 17.5.1.1 Automated bioassay infrastructure and disease-focused discovery programs to drive growth
- 17.5.2 MEXICO
- 17.5.2.1 Cost-efficient discovery capacity, antimicrobial research, and automated assay adoption to drive growth
- 17.5.3 REST OF LATIN AMERICA
- 17.5.1 BRAZIL
- 17.6 MIDDLE EAST
- 17.6.1 GCC COUNTRIES
- 17.6.1.1 Saudi Arabia
- 17.6.1.1.1 Growing pharmaceuticals industry to support market growth
- 17.6.1.2 UAE
- 17.6.1.2.1 Precision medicine investment, automated laboratory infrastructure, and AI-enabled discovery workflows to boost market growth
- 17.6.1.3 Rest of GCC Countries
- 17.6.1.1 Saudi Arabia
- 17.6.2 REST OF MIDDLE EAST
- 17.6.1 GCC COUNTRIES
- 17.7 AFRICA
- 17.7.1 INFECTIOUS DISEASE RESEARCH AND SHARED DISCOVERY NETWORKS TO AID MARKET GROWTH
18 COMPETITIVE LANDSCAPE
- 18.1 OVERVIEW
- 18.2 KEY PLAYER STRATEGY/RIGHT TO WIN
- 18.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HIGH-THROUGHPUT SCREENING (HTS) MARKET
- 18.3 REVENUE ANALYSIS, 2021-2025
- 18.4 MARKET SHARE ANALYSIS, 2025
- 18.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS, 2025
- 18.5.1 STARS
- 18.5.2 EMERGING LEADERS
- 18.5.3 PERVASIVE PLAYERS
- 18.5.4 PARTICIPANTS
- 18.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
- 18.5.5.1 Company footprint
- 18.5.5.2 Region footprint
- 18.5.5.3 Offering footprint
- 18.5.5.4 Product type footprint
- 18.5.5.5 Application footprint
- 18.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 18.6.1 PROGRESSIVE COMPANIES
- 18.6.2 RESPONSIVE COMPANIES
- 18.6.3 DYNAMIC COMPANIES
- 18.6.4 STARTING BLOCKS
- 18.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
- 18.6.5.1 Detailed list of key startups/SMEs
- 18.6.5.2 Competitive benchmarking of key startups/SMEs
- 18.7 COMPANY VALUATION & FINANCIAL METRICS
- 18.7.1 FINANCIAL METRICS
- 18.7.2 COMPANY VALUATION
- 18.8 BRAND/PRODUCT/SERVICE COMPARISON
- 18.9 COMPETITIVE SCENARIO
- 18.9.1 PRODUCT LAUNCHES
- 18.9.2 DEALS
- 18.9.3 EXPANSIONS
19 COMPANY PROFILES
- 19.1 KEY PLAYERS
- 19.1.1 THERMO FISHER SCIENTIFIC INC.
- 19.1.1.1 Business overview
- 19.1.1.2 Products & services offered
- 19.1.1.3 Recent developments
- 19.1.1.3.1 Product launches
- 19.1.1.3.2 Deals
- 19.1.1.3.3 Expansions
- 19.1.1.4 MnM view
- 19.1.1.4.1 Right to win
- 19.1.1.4.2 Strategic choices
- 19.1.1.4.3 Weaknesses & competitive threats
- 19.1.2 DANAHER CORPORATION
- 19.1.2.1 Business overview
- 19.1.2.2 Products & services offered
- 19.1.2.3 Recent developments
- 19.1.2.3.1 Product & service launches
- 19.1.2.3.2 Deals
- 19.1.2.4 MnM view
- 19.1.2.4.1 Right to win
- 19.1.2.4.2 Strategic choices
- 19.1.2.4.3 Weaknesses & competitive threats
- 19.1.3 MERCK KGAA
- 19.1.3.1 Business overview
- 19.1.3.2 Products & services offered
- 19.1.3.3 Recent developments
- 19.1.3.3.1 Deals
- 19.1.3.3.2 Expansions
- 19.1.3.3.3 Other developments
- 19.1.3.4 MnM view
- 19.1.3.4.1 Right to win
- 19.1.3.4.2 Strategic choices
- 19.1.3.4.3 Weaknesses & competitive threats
- 19.1.4 AGILENT TECHNOLOGIES, INC.
- 19.1.4.1 Business overview
- 19.1.4.2 Products & services offered
- 19.1.4.3 Recent developments
- 19.1.4.3.1 Product launches & upgrades
- 19.1.4.3.2 Deals
- 19.1.4.3.3 Expansions
- 19.1.4.3.4 Other developments
- 19.1.4.4 MnM view
- 19.1.4.4.1 Right to win
- 19.1.4.4.2 Strategic choices
- 19.1.4.4.3 Weaknesses & competitive threats
- 19.1.5 REVVITY, INC.
- 19.1.5.1 Business overview
- 19.1.5.2 Products & services offered
- 19.1.5.3 Recent developments
- 19.1.5.3.1 Product launches
- 19.1.5.3.2 Deals
- 19.1.5.4 MnM view
- 19.1.5.4.1 Right to win
- 19.1.5.4.2 Strategic choices
- 19.1.5.4.3 Weaknesses & competitive threats
- 19.1.6 TECAN GROUP LTD.
- 19.1.6.1 Business overview
- 19.1.6.2 Products & service offered
- 19.1.6.3 Recent developments
- 19.1.6.3.1 Product launches
- 19.1.6.3.2 Deals
- 19.1.7 BIO-RAD LABORATORIES, INC.
- 19.1.7.1 Business overview
- 19.1.7.2 Products & services offered
- 19.1.7.3 Recent developments
- 19.1.7.3.1 Product launches
- 19.1.8 CORNING INCORPORATED
- 19.1.8.1 Business overview
- 19.1.8.2 Products & services offered
- 19.1.9 METTLER-TOLEDO INTERNATIONAL INC.
- 19.1.9.1 Business overview
- 19.1.9.2 Products & services offered
- 19.1.10 LONZA GROUP
- 19.1.10.1 Business overview
- 19.1.10.2 Products & services offered
- 19.1.11 WATERS CORPORATION
- 19.1.11.1 Business overview
- 19.1.11.2 Products & services offered
- 19.1.11.3 Recent developments
- 19.1.11.3.1 Product launches
- 19.1.11.3.2 Deals
- 19.1.12 SARTORIUS AG
- 19.1.12.1 Business overview
- 19.1.12.2 Products & services offered
- 19.1.12.3 Recent developments
- 19.1.12.3.1 Product launches
- 19.1.12.3.2 Deals
- 19.1.12.3.3 Expansions
- 19.1.13 EPPENDORF SE
- 19.1.13.1 Business overview
- 19.1.13.2 Products & services offered
- 19.1.13.3 Recent developments
- 19.1.13.3.1 Product launches
- 19.1.13.3.2 Deals
- 19.1.13.3.3 Expansions
- 19.1.14 PORVAIR PLC
- 19.1.14.1 Business overview
- 19.1.14.2 Products & services offered
- 19.1.15 GREINER AG
- 19.1.15.1 Business overview
- 19.1.15.2 Products & services offered
- 19.1.16 CHARLES RIVER LABORATORIES
- 19.1.16.1 Business overview
- 19.1.16.2 products & services offered
- 19.1.16.3 Recent developments
- 19.1.16.3.1 Deals
- 19.1.17 EUROFINS SCIENTIFIC
- 19.1.17.1 Business overview
- 19.1.17.2 Products & services offered
- 19.1.17.3 Recent developments
- 19.1.17.3.1 Service launches
- 19.1.17.3.2 Deals
- 19.1.17.3.3 Expansions
- 19.1.18 HAMILTON COMPANY
- 19.1.18.1 Business overview
- 19.1.18.2 Products & services offered
- 19.1.18.3 Recent developments
- 19.1.18.3.1 Product launches
- 19.1.18.3.2 Deals
- 19.1.19 AURORA BIOMED INC.
- 19.1.19.1 Business overview
- 19.1.19.2 Products & services offered
- 19.1.20 GILSON INCORPORATED
- 19.1.20.1 Business overview
- 19.1.20.2 Products & services offered
- 19.1.21 BRAND GMBH + CO KG
- 19.1.21.1 Business overview
- 19.1.21.2 Products & services offered
- 19.1.1 THERMO FISHER SCIENTIFIC INC.
- 19.2 OTHER PLAYERS
- 19.2.1 BMG LABTECH GMBH
- 19.2.2 DIANA BIOTECHNOLOGIES, A.S.
- 19.2.3 CREATIVE BIOLABS
- 19.2.4 HIGHRES BIOSOLUTIONS
- 19.2.5 BIOMAT SRL
- 19.2.6 AXXAM S.P.A.
- 19.2.7 SYGNATURE DISCOVERY LIMITED
- 19.2.8 CROWN BIOSCIENCE
20 RESEARCH METHODOLOGY
- 20.1 RESEARCH DATA
- 20.1.1 SECONDARY DATA
- 20.1.1.1 Key secondary sources
- 20.1.1.2 Key data from secondary research
- 20.1.2 PRIMARY DATA
- 20.1.2.1 Key primary participants
- 20.1.2.2 Breakdown of primary interviews
- 20.1.2.3 Key data from primary sources
- 20.1.1 SECONDARY DATA
- 20.2 MARKET SIZE ESTIMATION
- 20.2.1 GLOBAL HIGH-THROUGHPUT SCREENING MARKET ESTIMATION, 2025
- 20.2.1.1 Approach 1: Company revenue analysis-based estimation (bottom-up)
- 20.2.1.2 Approach 2: Primary research
- 20.2.1.2.1 Key industry insights
- 20.2.1.3 Approach 3: MnM repository analysis
- 20.2.2 SEGMENTAL MARKET SIZE ESTIMATION, 2025
- 20.2.1 GLOBAL HIGH-THROUGHPUT SCREENING MARKET ESTIMATION, 2025
- 20.3 MARKET GROWTH RATE PROJECTIONS
- 20.4 DATA TRIANGULATION
- 20.5 RESEARCH ASSUMPTIONS
- 20.6 RESEARCH LIMITATIONS AND RISK ASSESSMENT
21 APPENDIX
- 21.1 DISCUSSION GUIDE
- 21.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 21.3 CUSTOMIZATION OPTIONS
- 21.4 RELATED REPORTS
- 21.5 AUTHOR DETAILS
List of Tables
- TABLE 1 HIGH-THROUGHPUT SCREENING (HTS) MARKET: INCLUSIONS & EXCLUSIONS
- TABLE 2 HIGH-THROUGHPUT SCREENING (HTS) MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
- TABLE 3 HIGH-THROUGHPUT SCREENING (HTS) MARKET: IMPACT OF PORTER'S FIVE FORCES
- TABLE 4 HIGH-THROUGHPUT SCREENING (HTS) MARKET: ROLE IN ECOSYSTEM
- TABLE 5 AVERAGE SELLING PRICE TREND OF HTS PRODUCTS, BY KEY PLAYER, 2023-2025 (USD)
- TABLE 6 AVERAGE SELLING PRICE TREND OF HTS PRODUCTS, BY REGION, 2023-2025 (USD)
- TABLE 7 IMPORT VALUE FOR HS CODE 902730, 2021-2025 (USD THOUSAND)
- TABLE 8 IMPORT VOLUME FOR HS CODE 902730, 2021-2025 (TONS)
- TABLE 9 IMPORT VALUE FOR HS CODE 902781, 2022-2025 (USD THOUSAND)
- TABLE 10 IMPORT VOLUME FOR HS CODE 902781, 2022-2025 (UNITS)
- TABLE 11 EXPORT VALUE FOR HS CODE 902730, BY COUNTRY, 2021-2025 (USD THOUSAND)
- TABLE 12 EXPORT VOLUME FOR HS CODE 902730, BY COUNTRY, 2021-2025 (TONS)
- TABLE 13 EXPORT VALUE FOR HS CODE 902781, 2022-2025 (USD THOUSAND)
- TABLE 14 EXPORT VOLUME FOR HS CODE 902781, 2022-2025 (UNITS)
- TABLE 15 HIGH-THROUGHPUT SCREENING (HTS) MARKET: KEY CONFERENCES & EVENTS, 2026-2027
- TABLE 16 US-ADJUSTED RECIPROCAL TARIFF RATES
- TABLE 17 HIGH-THROUGHPUT SCREENING (HTS) MARKET: INDICATIVE LIST OF PATENTS, 2026
- TABLE 18 CASE STUDIES OF AI IMPLEMENTATION IN HIGH-THROUGHPUT SCREENING (HTS) MARKET
- TABLE 19 CLIENT'S READINESS TO ADOPT GENERATIVE AI IN HIGH-THROUGHPUT SCREENING
- TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 23 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 24 US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION
- TABLE 25 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
- TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
- TABLE 27 KEY BUYING CRITERIA, BY END USER
- TABLE 28 HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 29 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 30 NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 31 EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 32 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 33 LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 34 MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 35 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 36 HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 37 NORTH AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 38 EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 39 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 40 LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 41 MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 42 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 43 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 44 HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 45 NORTH AMERICA: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 46 EUROPE: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, 2024-2031 (USD MILLION)
- TABLE 47 ASIA PACIFIC: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 48 LATIN AMERICA: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 49 MIDDLE EAST: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 50 GCC COUNTRIES: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 51 HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 52 SCREENING ASSAY KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 53 NORTH AMERICA: SCREENING ASSAY KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 54 EUROPE: SCREENING ASSAY KITS MARKET, 2024-2031 (USD MILLION)
- TABLE 55 ASIA PACIFIC: SCREENING ASSAY KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 56 LATIN AMERICA: SCREENING ASSAY KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 57 MIDDLE EAST: SCREENING ASSAY KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 58 GCC COUNTRIES: SCREENING ASSAY KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 59 SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 60 CELL-BASED ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 61 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 62 EUROPE: CELL-BASED ASSAYS MARKET, 2024-2031 (USD MILLION)
- TABLE 63 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 64 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 65 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 66 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 67 CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 68 CELL VIABILITY ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 69 NORTH AMERICA: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 70 EUROPE: CELL VIABILITY ASSAYS MARKET, 2024-2031 (USD MILLION)
- TABLE 71 ASIA PACIFIC: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 72 LATIN AMERICA: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 73 MIDDLE EAST: CELL VIABILITY ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 74 GCC COUNTRIES: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 75 CYTOTOXICITY ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 76 NORTH AMERICA: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 77 EUROPE: CYTOTOXICITY ASSAYS MARKET, 2024-2031 (USD MILLION)
- TABLE 78 ASIA PACIFIC: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 79 LATIN AMERICA: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 80 MIDDLE EAST: CYTOTOXICITY ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 81 GCC COUNTRIES: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 82 REPORTER GENE ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 83 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 84 EUROPE: REPORTER GENE ASSAYS MARKET, 2024-2031 (USD MILLION)
- TABLE 85 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 86 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 87 MIDDLE EAST: REPORTER GENE ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 88 GCC COUNTRIES: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 89 OTHER CELL-BASED ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 90 NORTH AMERICA: OTHER CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 91 EUROPE: OTHER CELL-BASED ASSAYS MARKET, 2024-2031 (USD MILLION)
- TABLE 92 ASIA PACIFIC: OTHER CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 93 LATIN AMERICA: OTHER CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 94 MIDDLE EAST: OTHER CELL-BASED ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 95 GCC COUNTRIES: OTHER CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 96 BIOCHEMICAL ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 97 NORTH AMERICA: BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 98 EUROPE: BIOCHEMICAL ASSAYS MARKET, 2024-2031 (USD MILLION)
- TABLE 99 ASIA PACIFIC: BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 100 LATIN AMERICA: BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 101 MIDDLE EAST: BIOCHEMICAL ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 102 GCC COUNTRIES: BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 103 BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 104 ENZYME ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 105 NORTH AMERICA: ENZYME ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 106 EUROPE: ENZYME ASSAYS MARKET, 2024-2031 (USD MILLION)
- TABLE 107 ASIA PACIFIC: ENZYME ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 108 LATIN AMERICA: ENZYME ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 109 MIDDLE EAST: ENZYME ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 110 GCC COUNTRIES: ENZYME ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 111 KINASE ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 112 NORTH AMERICA: KINASE ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 113 EUROPE: KINASE ASSAYS MARKET, 2024-2031 (USD MILLION)
- TABLE 114 ASIA PACIFIC: KINASE ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 115 LATIN AMERICA: KINASE ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 116 MIDDLE EAST: KINASE ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 117 GCC COUNTRIES: KINASE ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 118 BINDING ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 119 NORTH AMERICA: BINDING ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 120 EUROPE: BINDING ASSAYS MARKET, 2024-2031 (USD MILLION)
- TABLE 121 ASIA PACIFIC: BINDING ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 122 LATIN AMERICA: BINDING ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 123 MIDDLE EAST: BINDING ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 124 GCC COUNTRIES: BINDING ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 125 OTHER BIOCHEMICAL ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 126 NORTH AMERICA: OTHER BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 127 EUROPE: OTHER BIOCHEMICAL ASSAYS MARKET, 2024-2031 (USD MILLION)
- TABLE 128 ASIA PACIFIC: OTHER BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 129 LATIN AMERICA: OTHER BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 130 MIDDLE EAST: OTHER BIOCHEMICAL ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 131 GCC COUNTRIES: OTHER BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 132 OTHER ASSAYS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 133 NORTH AMERICA: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 134 EUROPE: OTHER ASSAYS & KITS MARKET, 2024-2031 (USD MILLION)
- TABLE 135 ASIA PACIFIC: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 136 LATIN AMERICA: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 137 MIDDLE EAST: OTHER ASSAYS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 138 GCC COUNTRIES: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 139 BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 140 NORTH AMERICA: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 141 EUROPE: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, 2024-2031 (USD MILLION)
- TABLE 142 ASIA PACIFIC: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 143 LATIN AMERICA: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 144 MIDDLE EAST: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 145 GCC COUNTRIES: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 146 COMPOUND LIBRARIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 147 NORTH AMERICA: COMPOUND LIBRARIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 148 EUROPE: COMPOUND LIBRARIES MARKET, 2024-2031 (USD MILLION)
- TABLE 149 ASIA PACIFIC: COMPOUND LIBRARIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 150 LATIN AMERICA: COMPOUND LIBRARIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 151 MIDDLE EAST: COMPOUND LIBRARIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 152 GCC COUNTRIES: COMPOUND LIBRARIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 153 DETECTION REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 154 NORTH AMERICA: DETECTION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 155 EUROPE: DETECTION REAGENTS MARKET, 2024-2031 (USD MILLION)
- TABLE 156 ASIA PACIFIC: DETECTION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 157 LATIN AMERICA: DETECTION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 158 MIDDLE EAST: DETECTION REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 159 GCC COUNTRIES: DETECTION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 160 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 161 NORTH AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 162 EUROPE: 3D CELL CULTURE PRODUCTS MARKET, 2024-2031 (USD MILLION)
- TABLE 163 ASIA PACIFIC: 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 164 LATIN AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 165 MIDDLE EAST: 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 166 GCC COUNTRIES: 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 167 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 168 SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 169 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 170 EUROPE: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, 2024-2031 (USD MILLION)
- TABLE 171 ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 172 LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 173 MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 174 GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 175 SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 176 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 177 EUROPE: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, 2024-2031 (USD MILLION)
- TABLE 178 ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 179 LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 180 MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 181 GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 182 OTHER 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 183 NORTH AMERICA: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 184 EUROPE: OTHER 3D CELL CULTURE PRODUCTS MARKET, 2024-2031 (USD MILLION)
- TABLE 185 ASIA PACIFIC: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 186 LATIN AMERICA: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 187 MIDDLE EAST: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 188 GCC COUNTRIES: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 189 OTHER HTS CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 190 NORTH AMERICA: OTHER HTS CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 191 EUROPE: OTHER HTS CONSUMABLES MARKET, 2024-2031 (USD MILLION)
- TABLE 192 ASIA PACIFIC: OTHER HTS CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 193 LATIN AMERICA: OTHER HTS CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 194 MIDDLE EAST: OTHER HTS CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 195 GCC COUNTRIES: OTHER HTS CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 196 HTS INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 197 NORTH AMERICA: HTS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 198 EUROPE: HTS INSTRUMENTS MARKET, 2024-2031 (USD MILLION)
- TABLE 199 ASIA PACIFIC: HTS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 200 LATIN AMERICA: HTS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 201 MIDDLE EAST: HTS INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 202 GCC COUNTRIES: HTS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 203 HTS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 204 DETECTION & IMAGING SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 205 NORTH AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 206 EUROPE: DETECTION & IMAGING SYSTEMS MARKET, 2024-2031 (USD MILLION)
- TABLE 207 ASIA PACIFIC: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 208 LATIN AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 209 MIDDLE EAST: DETECTION & IMAGING SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 210 GCC COUNTRIES: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 211 DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 212 MICROPLATE READERS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 213 NORTH AMERICA: MICROPLATE READERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 214 EUROPE: MICROPLATE READERS MARKET, 2024-2031 (USD MILLION)
- TABLE 215 ASIA PACIFIC: MICROPLATE READERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 216 LATIN AMERICA: MICROPLATE READERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 217 MIDDLE EAST: MICROPLATE READERS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 218 GCC COUNTRIES: MICROPLATE READERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 219 HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 220 NORTH AMERICA: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 221 EUROPE: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, 2024-2031 (USD MILLION)
- TABLE 222 ASIA PACIFIC: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 223 LATIN AMERICA: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 224 MIDDLE EAST: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 225 GCC COUNTRIES: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 226 CELL ANALYSIS SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 227 NORTH AMERICA: CELL ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 228 EUROPE: CELL ANALYSIS SYSTEMS MARKET, 2024-2031 (USD MILLION)
- TABLE 229 ASIA PACIFIC: CELL ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 230 LATIN AMERICA: CELL ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 231 MIDDLE EAST: CELL ANALYSIS SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 232 GCC COUNTRIES: CELL ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 233 LABEL-FREE DETECTION SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 234 NORTH AMERICA: LABEL-FREE DETECTION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 235 EUROPE: LABEL-FREE DETECTION SYSTEMS MARKET, 2024-2031 (USD MILLION)
- TABLE 236 ASIA PACIFIC: LABEL-FREE DETECTION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 237 LATIN AMERICA: LABEL-FREE DETECTION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 238 MIDDLE EAST: LABEL-FREE DETECTION SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 239 GCC COUNTRIES: LABEL-FREE DETECTION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 240 MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 241 NORTH AMERICA: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 242 EUROPE: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, 2024-2031 (USD MILLION)
- TABLE 243 ASIA PACIFIC: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 244 LATIN AMERICA: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 245 MIDDLE EAST: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 246 GCC COUNTRIES: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 247 LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 248 NORTH AMERICA: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 249 EUROPE: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, 2024-2031 (USD MILLION)
- TABLE 250 ASIA PACIFIC: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 251 LATIN AMERICA: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 252 MIDDLE EAST: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 253 GCC COUNTRIES: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 254 ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 255 NORTH AMERICA: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 256 EUROPE: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, 2024-2031 (USD MILLION)
- TABLE 257 ASIA PACIFIC: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 258 LATIN AMERICA: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 259 MIDDLE EAST: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 260 GCC COUNTRIES: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 261 OTHER HTS INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 262 NORTH AMERICA: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 263 EUROPE: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 264 ASIA PACIFIC: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 265 LATIN AMERICA: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 266 MIDDLE EAST: OTHER HTS INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 267 GCC COUNTRIES: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 268 HTS SOFTWARE & INFORMATICS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 269 NORTH AMERICA: HTS SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 270 EUROPE: HTS SOFTWARE & INFORMATICS MARKET, 2024-2031 (USD MILLION)
- TABLE 271 ASIA PACIFIC: HTS SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 272 LATIN AMERICA: HTS SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 273 MIDDLE EAST: HTS SOFTWARE & INFORMATICS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 274 GCC COUNTRIES: HTS SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 275 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 276 CELL-BASED SCREENING TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 277 NORTH AMERICA: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 278 EUROPE: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 279 ASIA PACIFIC: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 280 LATIN AMERICA: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 281 MIDDLE EAST: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 282 GCC COUNTRIES: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 283 ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 284 NORTH AMERICA: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 285 EUROPE: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 286 ASIA PACIFIC: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 287 LATIN AMERICA: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 288 MIDDLE EAST: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 289 GCC COUNTRIES: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 290 HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 291 NORTH AMERICA: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 292 EUROPE: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 293 ASIA PACIFIC: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 294 LATIN AMERICA: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 295 MIDDLE EAST: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 296 GCC COUNTRIES: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 297 BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 298 NORTH AMERICA: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 299 EUROPE: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 300 ASIA PACIFIC: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 301 LATIN AMERICA: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 302 MIDDLE EAST: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 303 GCC COUNTRIES: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 304 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 305 NORTH AMERICA: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 306 EUROPE: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 307 ASIA PACIFIC: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 308 LATIN AMERICA: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 309 MIDDLE EAST: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 310 GCC COUNTRIES: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 311 LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 312 NORTH AMERICA: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 313 EUROPE: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 314 ASIA PACIFIC: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 315 LATIN AMERICA: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 316 MIDDLE EAST: LABEL-FREE SCREENING TECHNOLOGIES MARKE T, BY REGION, 2024-2031 (USD MILLION)
- TABLE 317 GCC COUNTRIES: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 318 OTHER HTS TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 319 NORTH AMERICA: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 320 EUROPE: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 321 ASIA PACIFIC: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 322 LATIN AMERICA: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 323 MIDDLE EAST: OTHER HTS TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 324 GCC COUNTRIES: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 325 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 326 HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY REGION, 2024-2031 (USD MILLION)
- TABLE 327 NORTH AMERICA: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 328 EUROPE: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 329 ASIA PACIFIC: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 330 LATIN AMERICA: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 331 MIDDLE EAST: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY REGION, 2024-2031 (USD MILLION)
- TABLE 332 GCC COUNTRIES: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 333 HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY REGION, 2024-2031 (USD MILLION)
- TABLE 334 NORTH AMERICA: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 335 EUROPE: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 336 ASIA PACIFIC: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 337 LATIN AMERICA: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 338 MIDDLE EAST: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY REGION, 2024-2031 (USD MILLION)
- TABLE 339 GCC COUNTRIES: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 340 HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY REGION, 2024-2031 (USD MILLION)
- TABLE 341 NORTH AMERICA: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 342 EUROPE: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 343 ASIA PACIFIC: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 344 LATIN AMERICA: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 345 MIDDLE EAST: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY REGION, 2024-2031 (USD MILLION)
- TABLE 346 GCC COUNTRIES: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 347 HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY REGION, 2024-2031 (USD MILLION)
- TABLE 348 NORTH AMERICA: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 349 EUROPE: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 350 ASIA PACIFIC: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 351 LATIN AMERICA: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 352 MIDDLE EAST: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY REGION, 2024-2031 (USD MILLION)
- TABLE 353 GCC COUNTRIES: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 354 HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY REGION, 2024-2031 (USD MILLION)
- TABLE 355 NORTH AMERICA: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 356 EUROPE: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 357 ASIA PACIFIC: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 358 LATIN AMERICA: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 359 MIDDLE EAST: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY REGION, 2024-2031 (USD MILLION)
- TABLE 360 GCC COUNTRIES: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 361 HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY REGION, 2024-2031 (USD MILLION)
- TABLE 362 NORTH AMERICA: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 363 EUROPE: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 364 ASIA PACIFIC: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 365 LATIN AMERICA: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 366 MIDDLE EAST: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY REGION, 2024-2031 (USD MILLION)
- TABLE 367 GCC COUNTRIES: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 368 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 369 HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 370 NORTH AMERICA: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 371 EUROPE: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 372 ASIA PACIFIC: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 373 LATIN AMERICA: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 374 MIDDLE EAST: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 375 GCC COUNTRIES: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 376 HTS PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 377 NORTH AMERICA: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 378 EUROPE: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 379 ASIA PACIFIC: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 380 LATIN AMERICA: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 381 MIDDLE EAST: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 382 GCC COUNTRIES: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 383 HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 384 NORTH AMERICA: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 385 EUROPE: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 386 ASIA PACIFIC: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 387 LATIN AMERICA: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 388 MIDDLE EAST: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 389 GCC COUNTRIES: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 390 HTS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 391 NORTH AMERICA: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 392 EUROPE: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 393 ASIA PACIFIC: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 394 LATIN AMERICA: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 395 MIDDLE EAST: HTS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 396 GCC COUNTRIES: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 397 HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 398 PRIMARY SCREENING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 399 NORTH AMERICA: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 400 EUROPE: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 401 ASIA PACIFIC: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 402 LATIN AMERICA: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 403 MIDDLE EAST: PRIMARY SCREENING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 404 GCC COUNTRIES: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 405 ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 406 NORTH AMERICA: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 407 EUROPE: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 408 ASIA PACIFIC: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 409 LATIN AMERICA: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 410 MIDDLE EAST: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 411 GCC COUNTRIES: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 412 SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 413 NORTH AMERICA: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 414 EUROPE: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 415 ASIA PACIFIC: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 416 LATIN AMERICA: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 417 MIDDLE EAST: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 418 GCC COUNTRIES: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 419 HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 420 NORTH AMERICA: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 421 EUROPE: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 422 ASIA PACIFIC: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 423 LATIN AMERICA: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 424 MIDDLE EAST: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 425 GCC COUNTRIES: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 426 COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 427 NORTH AMERICA: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 428 EUROPE: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 429 ASIA PACIFIC: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 430 LATIN AMERICA: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 431 MIDDLE EAST: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 432 GCC COUNTRIES: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 433 DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 434 NORTH AMERICA: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 435 EUROPE: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 436 ASIA PACIFIC: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 437 LATIN AMERICA: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 438 MIDDLE EAST: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 439 GCC COUNTRIES: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 440 OTHER HTS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 441 NORTH AMERICA: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 442 EUROPE: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 443 ASIA PACIFIC: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 444 LATIN AMERICA: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 445 MIDDLE EAST: OTHER HTS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 446 GCC COUNTRIES: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 447 HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 448 HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 449 NORTH AMERICA: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 450 EUROPE: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 451 ASIA PACIFIC: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 452 LATIN AMERICA: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 453 MIDDLE EAST: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 454 GCC COUNTRIES: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 455 HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 456 NORTH AMERICA: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 457 EUROPE: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 458 ASIA PACIFIC: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 459 LATIN AMERICA: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 460 MIDDLE EAST: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 461 GCC COUNTRIES: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 462 HTS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 463 NORTH AMERICA: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 464 EUROPE: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 465 ASIA PACIFIC: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 466 LATIN AMERICA: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 467 MIDDLE EAST: HTS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 468 GCC COUNTRIES: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 469 HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 470 HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024-2031 (USD MILLION)
- TABLE 471 NORTH AMERICA: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 472 EUROPE: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 473 ASIA PACIFIC: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 474 LATIN AMERICA: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 475 MIDDLE EAST: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024-2031 (USD MILLION)
- TABLE 476 GCC COUNTRIES: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 477 HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 478 NORTH AMERICA: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 479 EUROPE: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 480 ASIA PACIFIC: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 481 LATIN AMERICA: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 482 MIDDLE EAST: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 483 GCC COUNTRIES: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 484 HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY REGION, 2024-2031 (USD MILLION)
- TABLE 485 NORTH AMERICA: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 486 EUROPE: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 487 ASIA PACIFIC: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 488 LATIN AMERICA: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 489 MIDDLE EAST: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY REGION, 2024-2031 (USD MILLION)
- TABLE 490 GCC COUNTRIES: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 491 HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY REGION, 2024-2031 (USD MILLION)
- TABLE 492 NORTH AMERICA: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 493 EUROPE: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 494 ASIA PACIFIC: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 495 LATIN AMERICA: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 496 MIDDLE EAST: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY REGION, 2024-2031 (USD MILLION)
- TABLE 497 GCC COUNTRIES: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 498 HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY REGION, 2024-2031 (USD MILLION)
- TABLE 499 NORTH AMERICA: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 500 EUROPE: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 501 ASIA PACIFIC: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 502 LATIN AMERICA: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 503 MIDDLE EAST: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY REGION, 2024-2031 (USD MILLION)
- TABLE 504 GCC COUNTRIES: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 505 HTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 506 NORTH AMERICA: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 507 EUROPE: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 508 ASIA PACIFIC: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 509 LATIN AMERICA: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 510 MIDDLE EAST: HTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 511 GCC COUNTRIES: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 512 HIGH-THROUGHPUT SCREENING MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 513 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 514 HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 515 NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 516 NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 517 NORTH AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 518 NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 519 NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 520 NORTH AMERICA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 521 NORTH AMERICA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 522 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 523 NORTH AMERICA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 524 NORTH AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 525 NORTH AMERICA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 526 NORTH AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 527 NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 528 NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 529 NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 530 NORTH AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 531 NORTH AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 532 NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 533 US: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 534 US: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 535 US: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 536 US: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 537 US: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 538 US: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 539 US: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 540 US: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 541 US: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 542 US: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 543 US: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 544 US: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 545 US: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 546 US: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 547 US: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 548 CANADA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 549 CANADA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 550 CANADA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 551 CANADA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 552 CANADA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 553 CANADA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 554 CANADA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 555 CANADA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 556 CANADA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 557 CANADA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 558 CANADA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 559 CANADA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 560 CANADA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 561 CANADA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 562 CANADA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 563 EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 564 EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 565 EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 566 EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 567 EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 568 EUROPE: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 569 EUROPE: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 570 EUROPE: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 571 EUROPE: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 572 EUROPE: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 573 EUROPE: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 574 EUROPE: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 575 EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 576 EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 577 EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 578 EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 579 EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 580 EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 581 GERMANY: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 582 GERMANY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 583 GERMANY: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 584 GERMANY: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 585 GERMANY: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 586 GERMANY: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 587 GERMANY: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 588 GERMANY: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 589 GERMANY: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 590 GERMANY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 591 GERMANY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 592 GERMANY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 593 GERMANY: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 594 GERMANY: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 595 GERMANY: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 596 UK: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 597 UK: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 598 UK: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 599 UK: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 600 UK: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 601 UK: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 602 UK: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 603 UK: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 604 UK: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 605 UK: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 606 UK: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 607 UK: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 608 UK: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 609 UK: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 610 UK: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 611 FRANCE: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 612 FRANCE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 613 FRANCE: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 614 FRANCE: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 615 FRANCE: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 616 FRANCE: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 617 FRANCE: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 618 FRANCE: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 619 FRANCE: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 620 FRANCE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 621 FRANCE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 622 FRANCE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 623 FRANCE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 624 FRANCE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 625 FRANCE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 626 ITALY: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 627 ITALY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 628 ITALY: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 629 ITALY: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 630 ITALY: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 631 ITALY: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 632 ITALY: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 633 ITALY: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 634 ITALY: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 635 ITALY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 636 ITALY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 637 ITALY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 638 ITALY: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 639 ITALY: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 640 ITALY: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 641 SPAIN: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 642 SPAIN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 643 SPAIN: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 644 SPAIN: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 645 SPAIN: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 646 SPAIN: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 647 SPAIN: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 648 SPAIN: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 649 SPAIN: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 650 SPAIN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 651 SPAIN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 652 SPAIN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 653 SPAIN: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 654 SPAIN: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 655 SPAIN: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 656 REST OF EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 657 REST OF EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 658 REST OF EUROPE: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 659 REST OF EUROPE: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 660 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 661 REST OF EUROPE: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 662 REST OF EUROPE: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 663 REST OF EUROPE: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 664 REST OF EUROPE: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 665 REST OF EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 666 REST OF EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 667 REST OF EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 668 REST OF EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 669 REST OF EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 670 REST OF EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 671 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 672 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 673 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 674 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 675 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 676 ASIA PACIFIC: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 677 ASIA PACIFIC: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 678 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 679 ASIA PACIFIC: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 680 ASIA PACIFIC: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 681 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 682 ASIA PACIFIC: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 683 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 684 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 685 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 686 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 687 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 688 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 689 CHINA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 690 CHINA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 691 CHINA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 692 CHINA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 693 CHINA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 694 CHINA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 695 CHINA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 696 CHINA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 697 CHINA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 698 CHINA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 699 CHINA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 700 CHINA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 701 CHINA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 702 CHINA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 703 CHINA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 704 JAPAN: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 705 JAPAN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 706 JAPAN: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 707 JAPAN: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 708 JAPAN: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 709 JAPAN: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 710 JAPAN: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 711 JAPAN: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 712 JAPAN: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 713 JAPAN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 714 JAPAN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 715 JAPAN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 716 JAPAN: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 717 JAPAN: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 718 JAPAN: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 719 INDIA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 720 INDIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 721 INDIA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 722 INDIA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 723 INDIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 724 INDIA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 725 INDIA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 726 INDIA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 727 INDIA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 728 INDIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 729 INDIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 730 INDIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 731 INDIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 732 INDIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 733 INDIA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 734 AUSTRALIA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 735 AUSTRALIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 736 AUSTRALIA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 737 AUSTRALIA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 738 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 739 AUSTRALIA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 740 AUSTRALIA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 741 AUSTRALIA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 742 AUSTRALIA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 743 AUSTRALIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 744 AUSTRALIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 745 AUSTRALIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 746 AUSTRALIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 747 AUSTRALIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 748 AUSTRALIA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 749 SOUTH KOREA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 750 SOUTH KOREA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 751 SOUTH KOREA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 752 SOUTH KOREA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 753 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 754 SOUTH KOREA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 755 SOUTH KOREA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 756 SOUTH KOREA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 757 SOUTH KOREA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 758 SOUTH KOREA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 759 SOUTH KOREA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 760 SOUTH KOREA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 761 SOUTH KOREA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 762 SOUTH KOREA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 763 SOUTH KOREA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 764 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 765 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 766 REST OF ASIA PACIFIC: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 767 REST OF ASIA PACIFIC: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 768 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 769 REST OF ASIA PACIFIC: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 770 REST OF ASIA PACIFIC: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 771 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 772 REST OF ASIA PACIFIC: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 773 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 774 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 775 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 776 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 777 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 778 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 779 LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 780 LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 781 LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 782 LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 783 LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 784 LATIN AMERICA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 785 LATIN AMERICA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 786 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 787 LATIN AMERICA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 788 LATIN AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 789 LATIN AMERICA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 790 LATIN AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 791 LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 792 LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 793 LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 794 LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 795 LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 796 LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 797 BRAZIL: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 798 BRAZIL: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 799 BRAZIL: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 800 BRAZIL: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 801 BRAZIL: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 802 BRAZIL: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 803 BRAZIL: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 804 BRAZIL: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 805 BRAZIL: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 806 BRAZIL: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 807 BRAZIL: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 808 BRAZIL: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 809 BRAZIL: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 810 BRAZIL: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 811 BRAZIL: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 812 MEXICO: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 813 MEXICO: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 814 MEXICO: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 815 MEXICO: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 816 MEXICO: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 817 MEXICO: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 818 MEXICO: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 819 MEXICO: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 820 MEXICO: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 821 MEXICO: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 822 MEXICO: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 823 MEXICO: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 824 MEXICO: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 825 MEXICO: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 826 MEXICO: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 827 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 828 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 829 REST OF LATIN AMERICA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 830 REST OF LATIN AMERICA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 831 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 832 REST OF LATIN AMERICA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 833 REST OF LATIN AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 834 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 835 REST OF LATIN AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 836 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 837 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 838 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 839 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 840 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 841 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 842 MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 843 MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 844 MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 845 MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 846 MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 847 MIDDLE EAST: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 848 MIDDLE EAST: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 849 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 850 MIDDLE EAST: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 851 MIDDLE EAST: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 852 MIDDLE EAST: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 853 MIDDLE EAST: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 854 MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 855 MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 856 MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 857 MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 858 MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 859 MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 860 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 861 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 862 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 863 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 864 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 865 GCC COUNTRIES: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 866 GCC COUNTRIES: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 867 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 868 GCC COUNTRIES: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 869 GCC COUNTRIES: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 870 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 871 GCC COUNTRIES: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 872 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 873 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 874 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 875 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 876 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 877 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 878 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 879 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 880 SAUDI ARABIA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 881 SAUDI ARABIA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 882 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 883 SAUDI ARABIA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 884 SAUDI ARABIA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 885 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 886 SAUDI ARABIA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 887 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 888 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 889 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 890 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 891 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 892 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 893 UAE: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 894 UAE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 895 UAE: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 896 UAE: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 897 UAE: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 898 UAE: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 899 UAE: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 900 UAE: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 901 UAE: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 902 UAE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 903 UAE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 904 UAE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 905 UAE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 906 UAE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 907 UAE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 908 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 909 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 910 REST OF GCC COUNTRIES: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 911 REST OF GCC COUNTRIES: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 912 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 913 REST OF GCC COUNTRIES: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 914 REST OF GCC COUNTRIES: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 915 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 916 REST OF GCC COUNTRIES: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 917 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 918 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 919 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 920 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 921 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 922 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 923 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 924 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 925 REST OF MIDDLE EAST: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 926 REST OF MIDDLE EAST: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 927 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 928 REST OF MIDDLE EAST: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 929 REST OF MIDDLE EAST: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 930 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 931 REST OF MIDDLE EAST: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 932 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 933 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 934 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 935 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 936 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 937 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 938 AFRICA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 939 AFRICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 940 AFRICA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 941 AFRICA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 942 AFRICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 943 AFRICA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 944 AFRICA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 945 AFRICA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 946 AFRICA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 947 AFRICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 948 AFRICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
- TABLE 949 AFRICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 950 AFRICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 951 AFRICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 952 AFRICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 953 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN HIGH-THROUGHPUT SCREENING MARKET
- TABLE 954 HIGH-THROUGHPUT SCREENING MARKET: DEGREE OF COMPETITION
- TABLE 955 HIGH-THROUGHPUT SCREENING MARKET: REGION FOOTPRINT
- TABLE 956 HIGH-THROUGHPUT SCREENING MARKET: OFFERING FOOTPRINT
- TABLE 957 HIGH-THROUGHPUT SCREENING MARKET: PRODUCT TYPE FOOTPRINT
- TABLE 958 HIGH-THROUGHPUT SCREENING MARKET: APPLICATION FOOTPRINT
- TABLE 959 HIGH-THROUGHPUT SCREENING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
- TABLE 960 HIGH-THROUGHPUT SCREENING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY OFFERING AND REGION
- TABLE 961 HIGH-THROUGHPUT SCREENING MARKET: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 962 HIGH-THROUGHPUT SCREENING MARKET: DEALS, JANUARY 2023-APRIL 2026
- TABLE 963 HIGH-THROUGHPUT SCREENING MARKET: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 964 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
- TABLE 965 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED
- TABLE 966 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 967 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023-APRIL 2026
- TABLE 968 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 969 DANAHER CORPORATION: COMPANY OVERVIEW
- TABLE 970 DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED
- TABLE 971 DANAHER CORPORATION: PRODUCT & SERVICE LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 972 DANAHER CORPORATION: DEALS, JANUARY 2023-APRIL 2026
- TABLE 973 MERCK KGAA: COMPANY OVERVIEW
- TABLE 974 MERCK KGAA: PRODUCTS & SERVICES OFFERED
- TABLE 975 MERCK KGAA: DEALS, JANUARY 2023-APRIL 2026
- TABLE 976 MERCK KGAA: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 977 MERCK KGAA: OTHER DEVELOPMENTS, JANUARY 2023-APRIL 2026
- TABLE 978 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
- TABLE 979 AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED
- TABLE 980 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-APRIL 2026
- TABLE 981 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023-APRIL 2026
- TABLE 982 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 983 AGILENT TECHNOLOGIES, INC.: OTHER DEVELOPMENTS, JANUARY 2023-APRIL 2026
- TABLE 984 REVVITY, INC.: COMPANY OVERVIEW
- TABLE 985 REVVITY INC.: PRODUCTS & SERVICES OFFERED
- TABLE 986 REVVITY, INC.: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 987 REVVITY, INC.: DEALS, JANUARY 2023-APRIL 2026
- TABLE 988 TECAN GROUP LTD.: COMPANY OVERVIEW
- TABLE 989 TECAN GROUP LTD.: PRODUCTS & SERVICES OFFERED
- TABLE 990 TECAN GROUP LTD.: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 991 TECAN GROUP LTD.: DEALS, JANUARY 2023-APRIL 2026
- TABLE 992 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
- TABLE 993 BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
- TABLE 994 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 995 CORNING INCORPORATED: COMPANY OVERVIEW
- TABLE 996 CORNING INCORPORATED: PRODUCTS & SERVICES OFFERED
- TABLE 997 METTLER-TOLEDO INTERNATIONAL INC.: COMPANY OVERVIEW
- TABLE 998 METTLER-TOLEDO INTERNATIONAL INC.: PRODUCTS & SERVICES OFFERED
- TABLE 999 LONZA GROUP: COMPANY OVERVIEW
- TABLE 1000 LONZA GROUP: PRODUCTS & SERVICES OFFERED
- TABLE 1001 WATERS CORPORATION: COMPANY OVERVIEW
- TABLE 1002 WATERS CORPORATION: PRODUCTS & SERVICES OFFERED
- TABLE 1003 WATERS CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 1004 WATERS CORPORATION: DEALS, JANUARY 2023-APRIL 2026
- TABLE 1005 SARTORIUS AG: COMPANY OVERVIEW
- TABLE 1006 SARTORIUS AG: PRODUCTS & SERVICES OFFERED
- TABLE 1007 SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 1008 SARTORIUS AG: DEALS, JANUARY 2023-APRIL 2026
- TABLE 1009 SARTORIUS AG: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 1010 EPPENDORF SE: COMPANY OVERVIEW
- TABLE 1011 EPPENDORF SE: PRODUCTS & SERVICES OFFERED
- TABLE 1012 EPPENDORF SE: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 1013 EPPENDORF SE: DEALS, JANUARY 2023-APRIL 2026
- TABLE 1014 EPPENDORF SE: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 1015 PORVAIR PLC: COMPANY OVERVIEW
- TABLE 1016 PORVAIR PLC: PRODUCTS & SERVICES OFFERED
- TABLE 1017 GREINER AG: COMPANY OVERVIEW
- TABLE 1018 GREINER AG: PRODUCTS & SERVICES OFFERED
- TABLE 1019 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY OVERVIEW
- TABLE 1020 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCTS & SERVICES OFFERED
- TABLE 1021 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: DEALS, JANUARY 2023-APRIL 2026
- TABLE 1022 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
- TABLE 1023 EUROFINS SCIENTIFIC: PRODUCTS & SERVICES OFFERED
- TABLE 1024 EUROFINS SCIENTIFIC: SERVICE LAUNCHES
- TABLE 1025 EUROFINS SCIENTIFIC: DEALS, JANUARY 2023-APRIL 2026
- TABLE 1026 EUROFINS SCIENTIFIC: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 1027 HAMILTON COMPANY: COMPANY OVERVIEW
- TABLE 1028 HAMILTON COMPANY: PRODUCTS & SERVICES OFFERED
- TABLE 1029 HAMILTON COMPANY: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 1030 HAMILTON COMPANY: DEALS, JANUARY 2023-APRIL 2026
- TABLE 1031 AURORA BIOMED INC.: COMPANY OVERVIEW
- TABLE 1032 AURORA BIOMED INC.: PRODUCTS & SERVICES OFFERED
- TABLE 1033 GILSON INCORPORATED: COMPANY OVERVIEW
- TABLE 1034 GILSON INCORPORATED: PRODUCTS & SERVICES OFFERED
- TABLE 1035 BRAND GMBH + CO KG: COMPANY OVERVIEW
- TABLE 1036 BRAND GMBH + CO KG: PRODUCTS & SERVICES OFFERED
- TABLE 1037 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
- TABLE 1038 RISK ASSESSMENT
List of Figures
- FIGURE 1 HTS MARKET SEGMENTATION
- FIGURE 2 REGIONS CONSIDERED
- FIGURE 3 HIGH-THROUGHPUT SCREENING MARKET: YEARS CONSIDERED
- FIGURE 4 MARKET SCENARIO
- FIGURE 5 GLOBAL HIGH-THROUGHPUT SCREENING MARKET, 2024-2031
- FIGURE 6 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HIGH-THROUGHPUT SCREENING MARKET, 2023-2026
- FIGURE 7 DISRUPTIONS INFLUENCING GROWTH OF HIGH-THROUGHPUT SCREENING MARKET
- FIGURE 8 HIGH-GROWTH SEGMENTS IN HIGH-THROUGHPUT SCREENING MARKET, 2026-2031
- FIGURE 9 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN HIGH-THROUGHPUT SCREENING MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
- FIGURE 10 GROWING ADOPTION OF OPEN INNOVATIVE MODELS TO DRIVE MARKET GROWTH
- FIGURE 11 US AND REAGENTS, KITS, AND CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF HIGH-THROUGHPUT SCREENING MARKET IN NORTH AMERICA IN 2025
- FIGURE 12 ASIA PACIFIC LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL HIGH-THROUGHPUT SCREENING MARKET DURING FORECAST PERIOD
- FIGURE 13 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD
- FIGURE 14 HIGH-THROUGHPUT SCREENING (HTS) MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 15 HIGH-THROUGHPUT SCREENING (HTS) MARKET: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 16 GLOBAL GDP GROWTH (2020-2030)
- FIGURE 17 HIGH-THROUGHPUT SCREENING (HTS) MARKET: VALUE CHAIN ANALYSIS
- FIGURE 18 HIGH-THROUGHPUT SCREENING (HTS) MARKET ECOSYSTEM
- FIGURE 19 AVERAGE SELLING PRICE TREND OF LIQUID HANDLING SYSTEMS, BY KEY PLAYER, 2023-2025 (USD)
- FIGURE 20 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2025 (USD)
- FIGURE 21 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN HIGH-THROUGHPUT SCREENING (HTS) MARKET
- FIGURE 22 TOP APPLICANTS/OWNERS (COMPANIES) FOR HIGH-THROUGHPUT SCREENING PATENTS, 2015-2025
- FIGURE 23 IMPACT OF AI/GEN AI ON HIGH-THROUGHPUT SCREENING (HTS) MARKET
- FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
- FIGURE 25 KEY BUYING CRITERIA, BY END USER
- FIGURE 26 FLOW CYTOMETRY INSTRUMENTS (CELL ANALYZERS) MARKET, 2024-2031 (UNITS)
- FIGURE 27 NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET SNAPSHOT
- FIGURE 28 ASIA PACIFIC: HIGHT-THROUGHPUT SCREENING MARKET SNAPSHOT
- FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS, 2021-2025 (USD MILLION)
- FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
- FIGURE 31 HIGH-THROUGHPUT SCREENING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
- FIGURE 32 HIGH-THROUGHPUT SCREENING MARKET: COMPANY FOOTPRINT
- FIGURE 33 HIGH-THROUGHPUT SCREENING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
- FIGURE 34 EV/EBITDA OF KEY VENDORS
- FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 36 HIGH-THROUGHPUT SCREENING MARKET: BRAND/PRODUCT/SERVICE COMPARATIVE ANALYSIS
- FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
- FIGURE 38 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
- FIGURE 39 MERCK KGAA: COMPANY SNAPSHOT (2025)
- FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 41 REVVITY, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 42 TECAN GROUP LTD.: COMPANY SNAPSHOT (2025)
- FIGURE 43 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 44 CORNING INCORPORATED: COMPANY SNAPSHOT (2025)
- FIGURE 45 METTLER-TOLEDO INTERNATIONAL INC.: COMPANY SNAPSHOT (2025)
- FIGURE 46 LONZA GROUP: COMPANY SNAPSHOT (2025)
- FIGURE 47 WATERS CORPORATION: COMPANY SNAPSHOT (2025)
- FIGURE 48 SARTORIUS AG: COMPANY SNAPSHOT (2025)
- FIGURE 49 EPPENDORF SE: COMPANY SNAPSHOT (2024)
- FIGURE 50 PORVAIR PLC: COMPANY SNAPSHOT (2025)
- FIGURE 51 GREINER AG: COMPANY SNAPSHOT (2025)
- FIGURE 52 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 53 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025)
- FIGURE 54 HIGHT-THROUGHPUT SCREENING MARKET: RESEARCH DESIGN
- FIGURE 55 HIGHT-THROUGHPUT SCREENING MARKET: BREAKDOWN OF PRIMARIES
- FIGURE 56 GLOBAL HIGH-THROUGHPUT SCREENING MARKET ESTIMATION, 2025
- FIGURE 57 HIGH-THROUGHPUT SCREENING MARKET: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH) (2025)
- FIGURE 58 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC: REVENUE ANALYSIS (2025)
- FIGURE 59 HIGH-THROUGHPUT SCREENING MARKET: INSIGHTS FROM PRIMARIES
- FIGURE 60 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
- FIGURE 61 HIGH-THROUGHPUT SCREENING MARKET: CAGR PROJECTIONS
- FIGURE 62 HTS MARKET: DATA TRIANGULATION
02-2729-4219
+886-2-2729-4219
高通量滴定系統市場：全球市場預測（2026-2032年）高通量篩檢市場－2026-2032年全球市場預測
高通量篩檢市場報告：按技術、產品和服務、應用、最終用戶和地區分類（2026-2034 年）
2026年全球高通量篩檢服務市場報告
高通量篩檢市場：按產品/服務、技術、應用、最終用戶和地區分類。高通量篩檢（HTS）全球市場報告（2026年）
高通量篩檢(HTS) 市場分析及至 2035 年預測：按類型、產品類型、服務、技術、組件、應用、最終用戶、流程、部署類型和功能分類高通量篩檢系統市場分析及預測（至2035年）：依類型、產品類型、服務、技術、組件、應用、最終使用者、流程、實施類型及實施階段分類
全球高通量篩檢市場規模、佔有率、趨勢和成長分析報告（2026-2034）
高通量篩檢（HTS）市場 2025-2029
▼